Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2026-01-11 @ 5:34 AM
Study NCT ID:
NCT06650332
Status:
RECRUITING
Last Update Posted:
2024-10-21
First Post:
2024-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Sponsor:
Zhejiang Cancer Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic HER2 Positive Gastroesophageal Junction Cancer | View |
Keywords: